SOCS2 and glioblastoma: Conversely, whereas SOCS2 was strongly associated with activating mutations in GBM (LFC = 1.91, FDR-adjusted P-value = 1.94e−15), it showed an inverse association to mutations in LUAD (LFC = −0.68, FDR-adjusted P-value = .007).